CDC Science Clips

Healthcare Economics

1. Blue Cross partners with state to provide childhood vaccines
   Idaho Department of Health and Welfare. 2009 June 15.


2. The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa
   Abimbola TO, Marston BJ.
   J Acquir Immune Defic Syndr. 2012 Jan 11.


3. Costs of, and reimbursement for, vaccines: a case study at the Board of Health Refugee Services in DeKalb county, Georgia
   Adachi K, Coleman MS, de la Motte Hurst C, Vargas ML, Oladele A, Weinberg MS.
   Vaccine. 2012 Aug 18.


4. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get with the Guidelines-Coronary Artery Disease program)
   Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, Krantz MJ.
   Am J Cardiol. 2010 ;105(2):139-43.


5. Medical expenditures of children in the United States with fetal alcohol syndrome
   Amendah DD, Grosse SD, Bertrand J.
   Neurotoxicol Teratol. 2011 Mar-Apr;33(2):322-4.


6. Estimates of state-level health-care expenditures associated with disability
   Anderson WL, Armour BS, Finkelstein EA, Wiener JM.
   Public Health Rep. 2010 January-February;125(1):44-51.


7. Coordination costs for school-located influenza vaccination clinics, Maine, 2009 H1N1 pandemic
   Asay GR, Cho BH, Lorick SA, Tipton ML, Dube NL, Messonnier ML.
   J Sch Nurs. 2012 Oct;28(5):328-35.


8. The impact of self-insuring for workers' compensation on the incidence rates of worker injury and illness
   Asfaw A, Pana-Cryan R.
   J Occup Environ Med. 2009 Nov 25.


9. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis
   Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG.
   Med Mycol. 2013 Feb;51(2):128-35.


10. Costs of asthma in the United States: 2002-2007
    Barnett SB, Nurmagambetov TA.
    J Allergy Clin Immunol. 2011 Jan;127(1):145-52.


11. Costs of asthma in the United States: 2002-2007
    Barnett SB, Nurmagambetov TA.
    J Allergy Clin Immunol. 2011 Jan;127(1):145-52.


12. HIV treatment as prevention: issues in economic evaluation
    Barnighausen T, Salomon JA, Sangrujee N.
    PLoS Med. 2012 Jul;9(7):e1001263.


13. Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic
    Basurto-Davila R, Garza R, Meltzer MI, Carlino OL, Albalak R, Orellano PW, Uez O, Shay DK, Santandrea C, Weis MD, Averhoff F, Widdowson MA.
    Influenza Other Respi Viruses. 2012 Nov 26.


14. Health economics of dengue: a systematic literature review and expert panel's assessment
    Beatty ME, Beutels P, Meltzer MI, Shepard DS, Hombach J, Hutubessy R, Dessis D, Coudeville L, Dervaux B, Wichmann O, Margolis HS, Kuritsky JN.
    Am J Trop Med Hyg. 2011 Mar;84(3):473-488.


15. Excess healthcare costs associated with prior workers' compensation activity
    Bhattacharya A, Park RM.
    Am J Ind Med. 2012 Sep 11.


16. Paid malpractice claims for adverse events in inpatient and outpatient settings
    Bishop TF, Ryan AK, Casalino LP.
    JAMA. 2011 Jun 15;305(23):2427-31.


17. The health and wealth of US counties: how the small business environment impacts alternative measures of development
    Blanchard TC, Tolbert C, Mencken C.
    Camb J Regions Econ Soc. 2011 December 2, 2011:1-14.


18. Dental insurance for persons under age 65 years with private health insurance: United States, 2008
    Bloom B, Cohen RA.
    NCHS Data Brief. 2010 Jun(40):1-8.


19. Health care expenditures associated with venous thromboembolism among children
    Boulet SL, Amendah D, Grosse SD, Hooper WC.
    Thromb Res. 2012 May;129(5):583-7.


20. Cost implications of self-management education intervention programmes in arthritis
    Brady TJ.
    Best Pract Res Clin Rheumatol. 2012 Oct;26(5):611-25.


21. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
    Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, Sisk J, Ruiz F, Hill S, Guyatt GH, Jaeschke R, Helfand M, Harbour R, Davoli M, Amato L, Liberati A, Schunemann HJ.
    J Clin Epidemiol. 2013 Feb;66(2):140-50.


22. Reference allocations and use of a disparity measure to inform the design of allocation funding formulas in public health programs
    Buehler JW, Bernet PM, Ogden LL.
    J Public Health Manag Pract. 2012 Jul;18(4):333-8.


23. Resource and cost adjustment in the design of allocation funding formulas in public health programs
    Buehler JW, Bernet PM, Ogden LL.
    J Public Health Manag Pract. 2012 Jul;18(4):323-32.


24. Health care expenditures among children with and those without spina bifida enrolled in Medicaid in North Carolina
    Cassell CH, Grosse SD, Thorpe PG, Howell EE, Meyer RE.
    Birth Defects Res A Clin Mol Teratol. 2011 Oct 22.


25. Sexonomics: a commentary and review of selected sexually transmitted disease studies in the economics literature
    Chesson HW.
    Sex Transm Dis. 2012 Mar;39(3):161-6.


26. The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV infection
    Chesson HW, Bernstein KT, Gift TL, Marcus JL, Pipkin S, Kent CK.
    Sex Transm Dis. 2013 May;40(5):366-71.


27. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
    Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE.
    Vaccine. 2012 Aug 3.


28. Costs of school-located influenza vaccination clinics in Maine during the 2009-2010 H1N1 pandemic
    Cho BH, Asay GR, Lorick SA, Tipton ML, Dube NL, Messonnier ML.
    J Sch Nurs. 2012 Oct;28(5):336-43.


29. A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics
    Cho BH, Hicks KA, Honeycutt AA, Hupert N, Khavjou O, Messonnier M, Washington ML.
    J Public Health Manag Pract. 2011 January/February;17(1):E22-E28.


30. Trends in medical care expenditures of US adults with arthritis and other rheumatic conditions 1997 to 2005
    Cisternas MG, Murphy LB, Yelin EH, Foreman AJ, Pasta DJ, Helmick CG.
    J Rheumatol. 2009 Oct 1.


31. Coverage of newborn and adult male circumcision varies among public and private US payers despite health benefits
    Clark SJ, Kilmarx PH, Kretsinger K.
    Health Aff (Millwood). 2011 Dec;30(12):2355-61.


32. Impact of type of insurance plan on access and utilization of health care services for adults aged 18-64 years with private health insurance: United States, 2007-2008
    Cohen RA.
    NCHS Data Brief. 2010 Feb(28):1-8.


33. Health insurance coverage: early release of estimates from the National Health Interview Survey, 2011
    Cohen RA, Martinez ME.
    Early Releases of Selected Estimates from the NHIS. 2012 June 19:1-37.


34. Net financial gain or loss from vaccination in pediatric medical practices
    Coleman MS, Lindley MC, Ekong J, Rodewald L.
    Pediatrics. 2009 ;124(SUPPL. 5):S472-S491.


35. Direct healthcare costs of selected diseases primarily or partially transmitted by water
    Collier SA, Stockman LJ, Hicks LA, Garrison LE, Zhou FJ, Beach MJ.
    Epidemiol Infect. 2012 Nov;140(11):2003-13.


36. Trends in healthcare utilization for diarrhea and rotavirus disease in privately insured US children <5 years of age, 2001-2006
    Cortes JE, Curns AT, Tate JE, Parashar UD.
    Pediatr Infect Dis J. 2009 Jul 9.


37. Health status and health insurance coverage of women with live-born infants: an opportunity for preventive services after pregnancy
    D'Angelo DV, Williams L, Harrison L, Ahluwalia IB.
    Matern Child Health J. 2012 Nov 4.


38. Changes in Medicaid physician fees and patterns of ambulatory care
    Decker SL.
    Inquiry. 2009 Fall;46(3):291-304.


39. Medicaid payment levels to dentists and access to dental care among children and adolescents
    Decker SL.
    JAMA. 2011 Jul 13;306(2):187-93.


40. In 2011 nearly one-third of physicians said they would not accept new Medicaid patients, but rising fees may help
    Decker SL.
    Health Aff (Millwood). 2012 Aug;31(8):1673-9.


41. Cost-benefit analysis of in-hospital influenza vaccination of postpartum women
    Ding Y, Zangwill KM, Hay JW, Allred NJ, Yeh SH.
    Obstet Gynecol. 2012 Feb;119(2 Pt 1):306-14.


42. Economic analysis of the global polio eradication initiative
    Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Linkins J, Sutter RW, Aylward RB, Thompson KM.
    Vaccine. 2010 Dec 16;29(2):334-43.


43. High costs of influenza: direct medical costs of influenza disease in young children
    Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, Donauer S, Henderson D, Ambrose S, Kent D, Poehling K, Weinberg GA, Griffin MR, Hall CB, Finelli L, Bridges C, Staat MA.
    Vaccine. 2010 Jul 12;28(31):4913-9.


44. The economic burden of child maltreatment in the United States and implications for prevention
    Fang X, Brown DS, Florence CS, Mercy JA.
    Child Abuse Negl. 2012 Jan 31.


45. Do reduced inpatient costs associated with highly active antiretroviral therapy (HAART) balance the overall cost for HIV treatment?
    Farnham PG.
    Appl Health Econ Health Policy. 2010 ;8(2):75-88.


46. Medical costs averted by HIV prevention efforts in the United States, 1991-2006
    Farnham PG, Holtgrave DR, Sansom SL, Hall HI.
    J Acquir Immune Defic Syndr. 2010 Aug 15;54(5):565-7.


47. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings
    Farnham PG, Sansom SL, Hutchinson AB.
    Med Decis Making. 2012 May-Jun;32(3):459-69.


48. Large cost savings realized from the 2006 Field Triage Guideline: reduction in overtriage in U.S. trauma centers
    Faul M, Wald MM, Sullivent EE, Sasser SM, Kapil V, Lerner EB, Hunt RC.
    Prehosp Emerg Care. 2011 Oct 18.


49. Health economics of cardiovascular disease: defining the research agenda
    Ferdinand KC, Orenstein D, Hong Y, Journigan JG, Trogdon J, Bowman J, Zohrabian A, Kilgore M, White A, Mokdad A, Pechacek TF, Goetzel RZ, Labarthe DR, Puckrein GA, Finkelstein E, Wang G, French ME, Vaccarino V.
    CVD Prev Control. 2011 September;6 (3):91-100.


50. The personal financial burden of cancer for the working-aged population
    Finkelstein EA, Tangka FK, Trogdon JG, Sabatino SA, Richardson LC.
    Am J Manag Care. 2009 Nov;15(11):801-6.


51. Annual medical spending attributable to obesity: payer-and service-specific estimates
    Finkelstein EA, Trogdon JG, Cohen JW, Dietz W.
    Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31.


52. Assessing cost effectiveness of empirical and prophylactic therapy for managing leptospirosis outbreaks
    Galloway RL, Levett PN, Tumeh JW, Flowers CR.
    Epidemiol Infect. 2009 Sep;137(9):1323-32.


53. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations
    Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.
    Drugs. 2012 Jan 1;72(1):35-48.


54. Financial barriers to the adoption of combination vaccines by pediatricians
    Gidengil CA, Dutta-Linn MM, Messonnier ML, Rusinak D, Lieu TA.
    Arch Pediatr Adolesc Med. 2010 Dec;164(12):1138-44.


55. Cost-effectiveness of the National HIV/AIDS Strategy (NHAS) goal of increasing linkage to care for HIV-infected persons
    Gopalappa C, Farnham PG, Hutchinson AB, Sansom SL.
    J Acquir Immune Defic Syndr. 2012 May 10.


56. Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study
    Gregg EW, Karter AJ, Gerzoff RB, Safford M, Brown AF, Tseng CW, Waitzfielder B, Herman WH, Mangione CM, Selby JV, Thompson TJ, Dudley RA.
    Med Care. 2009 Dec 8.


57. What is the value for money of prenatal carrier screening for spina muscular atrophy? Too soon to say
    Grosse SD.
    Am J Obstet Gynecol. 2010 Mar;202(3):209-11.


58. Incidence-based cost estimates require population-based incidence data. A critique of Mahan et al
    Grosse SD.
    Thromb Haemost. 2011 Dec 8;107(1).


59. Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008
    Guh S, Grosse SD, McAlister S, Kessler CM, Soucie JM.
    Haemophilia. 2011 Dec 12.


60. Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008
    Guh S, Grosse SD, McAlister S, Kessler CM, Soucie JM.
    Haemophilia. 2012 Mar;18(2):276-83.


61. Cost-effectiveness of a behavioral weight loss intervention for low-income women: the Weight-Wise Program
    Gustafson A, Khavjou O, Stearns SC, Keyserling TC, Gizlice Z, Lindsley S, Bramble K, Garcia B, Johnston L, Will J, Poindexter P, Ammerman AS, Samuel-Hodge CD.
    Prev Med. 2009 Nov;49(5):390-5.


62. Melanoma treatment costs: a systematic review of the literature, 1990-2011
    Guy GP, Ekwueme DU, Tangka FK, Richardson LC.
    Am J Prev Med. 2012 Nov;43(5):537-45.


63. Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective
    Holmes CB, Atun R, Avila C, Blandford JM.
    J Acquir Immune Defic Syndr. 2011 01 Aug;57 (SUPPL. 2):S104-S108.


64. Healthcare utilization and cost of pneumococcal disease in the United States
    Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA.
    Vaccine. 2011 Apr 18;29(18):3398-412.


65. Return on public health investment: CDC's expanded HIV testing initiative
    Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH.
    J Acquir Immune Defic Syndr. 2011 Nov 7.


66. Economics of collaborative care for management of depressive disorders: a community guide systematic review
    Jacob V, Chattopadhyay SK, Sipe TA, Thota AB, Byard GJ, Chapman DP.
    Am J Prev Med. 2012 May;42(5):539-49.


67. Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness
    Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S.
    PLoS One. 2012 ;7(2):e31316.


68. Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children
    Kancherla V, Amendah DD, Grosse SD, Yeargin-Allsopp M, Van Naarden Braun K.
    Res Dev Disabil. 2012 Jan 11;33(3):832-840.


69. Reducing health care costs for dementia patients: estimating savings from a caregiver support program
    Klug MG, Muus K, Volkov B, Halaas GW.
    J Aging Health. 2012 Dec;24(8):1470-85.


70. Underinsurance among children in the United States
    Kogan MD, Newacheck PW, Blumberg SJ, Ghandour RM, Singh GK, Strickland BB, van Dyck PC.
    N Engl J Med. 2010 Aug 26;363(9):841-51.


71. State variation in underinsurance among children with special health care needs in the United States
    Kogan MD, Newacheck PW, Blumberg SJ, Heyman KM, Strickland BB, Singh GK, Zeni MB.
    Pediatrics. 2010 Apr;125(4):673-80.


72. Allocating HIV prevention funds in the United States: recommendations from an optimization model
    Lasry A, Sansom SL, Hicks KA, Uzunangelov V.
    PLoS One. 2012 ;7(6):e37545.


73. Showcasing pharmaceutical economics, outcomes, and health policy: an update in clinical therapeutics
    Lau DT.
    Clin Ther. 2013 Apr;35(4):354-5.


74. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review
    Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X.
    Diabetes Care. 2010 Aug;33(8):1872-94.


75. Estimating the impact of state budget cuts and redirection of prevention resources on the HIV epidemic in 59 California local health departments
    Lin F, Lasry A, Sansom SL, Wolitski RJ.
    PLoS One. 2013 ;8(3):e55713.


76. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs
    Lin JM, Resch SC, Brimmer DJ, Johnson A, Kennedy S, Burstein N, Simon CJ.
    Cost Eff Resour Alloc. 2011 ;9(1):1.


77. Billing practices of local health departments providing 2009 pandemic influenza A (H1N1) vaccine
    Lindley MC.
    J Public Health Manag Pract. 2013 Jan 28.


78. Financing vaccination of children and adolescents: National Vaccine Advisory Committee recommendations
    Lindley MC, Birkhead GS, Almquist JR, Clover RD, Dekker C, Feinberg M, Fergie J, Gordon LK, Humiston SG, Jackson LA, Lovell Jr C, Mason JO, McCormick M, Nevin-Woods C, Parnell T, Pavia A, Riley LE, Abramson JS, Coleman MS, Edwards B, Freed GL, Gellin B, Greenbaum E, Haddix AC, Hinman AR, Johnson CB, Kelman J, Klein JO, Orenstein WA, Pauly M, Pisani AA, Rodewald LE, Rosenberg A, Salesa J, Shen AK, Wallace G, Wilson JJ, Wisniewski AC.
    Pediatrics. 2009 ;124(SUPPL. 5):S558-S562.


79. Financing the delivery of vaccines to children and adolescents: challenges to the current system
    Lindley MC, Shen AK, Orenstein WA, Rodewald LE, Birkhead GS.
    Pediatrics. 2009 ;124(SUPPL. 5):S548-S557.


80. Advancing the science of health care costing
    Lipscomb J, Barnett PG, Brown ML, Lawrence W, Yabroff KR.
    Med Care. 2009 Jul;47(7 Suppl 1):S120-6.[Request a copy via DocExpress]
    


81. Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families
    Mahamud A, Fiebelkorn AP, Nelson G, Aguon A, McKenna J, Villarruel G, Gallagher K, Ortega-Sanchez IR.
    Vaccine. 2012 Aug 14.


82. Aligning resources to fight HIV/AIDS in the United States: funding to states through the U.S. Department of Health and Human Services
    Mansergh G, Valdiserri RO, Yakovchenko V, Koh H.
    J Acquir Immune Defic Syndr. 2011 Dec 12.


83. The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda
    Marseille E, Kahn JG, Pitter C, Bunnell R, Epalatai W, Jawe E, Were W, Mermin J.
    Appl Health Econ Health Policy. 2009 ;7(4):229-43.


84. Coverage and preventive screening
    Meeker D, Joyce GF, Malkin J, Teutsch SM, Haddix AC, Goldman DP.
    Health Serv Res. 2010 Oct 28.


85. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs
    Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM.
    AIDS. 2011 Mar 15.


86. The determinants of HIV treatment costs in resource limited settings
    Menzies NA, Berruti AA, Blandford JM.
    PLoS One. 2012 ;7(11):e48726.


87. Economics of monitoring antiretroviral therapy
    Mermin J, Granich R.
    Lancet Infect Dis. 2013 Apr 17.


88. The societal cost of tuberculosis: Tarrant County, Texas, 2002
    Miller TL, McNabb SJ, Hilsenrath P, Pasipanodya J, Drewyer G, Weis SE.
    Ann Epidemiol. 2010 Jan;20(1):1-7.


89. Why behavioral and environmental interventions are needed to improve health at lower cost
    Milstein B, Homer J, Briss P, Burton D, Pechacek T.
    Health Aff (Millwood). 2011 May;30(5):823-32.


90. Introduction to special issue of best practices in rheumatology: health economics of musculoskeletal diseases
    Murphy LB, Yelin E.
    Best Pract Res Clin Rheumatol. 2012 Oct;26(5):559-60.


91. Compromised access to prescriptions and medical care because of cost among US adults with arthritis
    Murphy LB, Yelin E, Theis KA.
    Best Pract Res Clin Rheumatol. 2012 Oct;26(5):677-94.


92. From the American Academy of Pediatrics: Policy statements--Supplemental Security Income (SSI) for children and youth with disabilities
    Murphy NA, Burke R, Desch LW, Duby JC, Elias ER, Levy SE, Liptak GS, McNeal D, Myers SM, Norwood Jr KW, Sagerman PJ, Peacock G, Council on Children With Disabilities.
    Pediatrics. 2009 Dec;124(6):1702-8.


93. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States
    Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD.
    Pediatr Blood Cancer. 2009 Oct;53(4):642-6.


94. Exposure to natural cold and heat: hypothermia and hyperthermia Medicare claims, United States, 2004-2005
    Noe RS, Jin JO, Wolkin AF.
    Am J Public Health. 2012 Apr;102(4):e11-8.


95. Funding formulas for public health allocations: federal and state strategies
    Ogden LL, Sellers K, Sammartino C, Buehler JW, Bernet PM.
    J Public Health Manag Pract. 2012 Jul;18(4):309-316.


96. Indirect, out-of-pocket and medical costs from influenza-related illness in young children
    Ortega-Sanchez IR, Molinari NA, Fairbrother G, Szilagyi PG, Edwards KM, Griffin MR, Cassedy A, Poehling KA, Bridges C, Staat MA.
    Vaccine. 2012 Apr 27.


97. Employment impact and financial burden for families of children with fragile X syndrome: findings from the National Fragile X Survey
    Ouyang L, Grosse S, Raspa M, Bailey D.
    J Intellect Disabil Res. 2010 Aug 26.


98. Healthcare expenditures for privately insured people with cystic fibrosis
    Ouyang L, Grosse SD, Amendah DD, Schechter MS.
    Pediatr Pulmonol. 2009 Sep 18;44(10):989-96.


99. Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007
    Owusu-Edusei Jr K, Hoover KW, Tao G.
    Sex Transm Dis. 2010 Sep 24.


100. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008
     Owusu-Edusei K, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC, Kent CK.
     Sex Transm Dis. 2013 Mar;40(3):197-201.


101. The direct cost of chlamydial infections: estimates for the employer-sponsored privately insured population in the United States, 2003-2007
     Owusu-Edusei K, Doshi SR, Apt BS, Gift TL.
     Sex Transm Dis. 2010 Apr 21.


102. Treatment cost of acute gonococcal infections: estimates from employer-sponsored private insurance claims data in the United States, 2003-2007
     Owusu-Edusei K, Gift TL, Chesson HW.
     Sex Transm Dis. 2010 Mar 8.


103. Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States
     Owusu-Edusei K, Introcaso CE, Chesson HW.
     Sex Transm Dis. 2013 Mar;40(3):226-9.


104. The tale of two serologic tests to screen for syphilis-treponemal and nontreponemal: does the order matter?
     Owusu-Edusei K, Koski KA, Ballard RC.
     Sex Transm Dis. 2010 Dec 22.


105. Utilization and cost of diagnostic methods for sexually transmitted infection screening among insured American youth, 2008
     Owusu-Edusei K, Nguyen HT, Gift TL.
     Sex Transm Dis. 2013 May;40(5):354-61.


106. Federal funding for reporting cases of HIV infection in the United States, 2006
     Page MJ, Harrison KM, Wei X, Hall HI.
     Public Health Rep. 2010 Sep-Oct;125(5):718-27.


107. Autism spectrum disorders and health care expenditures: the effects of co-occurring conditions
     Peacock G, Amendah D, Ouyang L, Grosse SD.
     J Dev Behav Pediatr. 2011 Dec 9.


108. Cost of rapid HIV testing at 45 U.S. hospitals
     Pinkerton SD, Bogart LM, Howerton D, Snyder S, Becker K, Asch SM.
     AIDS Patient Care STDS. 2010 Jul;24(7):409-13.


109. Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis
     Prabhu VS, Farnham PG, Hutchinson AB, Soorapanth S, Heffelfinger JD, Golden MR, Brooks JT, Rimland D, Sansom SL.
     PLoS One. 2011 ;6(5):e19936.


110. Decision analysis, economic evaluation, and newborn screening: challenges and opportunities
     Prosser LA, Grosse SD, Kemper AR, Tarini BA, Perrin JM.
     Genet Med. 2012 August;14(8):703-712.


111. Health utility elicitation: is there still a role for direct methods?
     Prosser LA, Grosse SD, Wittenberg E.
     PharmacoEconomics. 2012 Feb 1;30(2):83-6.


112. Billing third party payers for vaccines: state and local health department perspectives
     Quintanilla C, Duncan L, Luther L.
     J Public Health Manag Pract. 2009 Sep-Oct;15(5):E1-5.


113. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States
     Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR.
     Vaccine. 2009 Nov 5;27(47):6483-94.


114. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings
     Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM.
     Ann Intern Med. 2011 Nov 4.


115. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy
     Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, Saaddine JB.
     Health Serv Res. 2011 Apr 14.


116. The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative Welcome to Medicare eye evaluation among persons without diagnosed diabetes mellitus
     Rein DB, Wittenborn JS, Zhang X, Hoerger TJ, Zhang P, Klein BE, Lee KE, Klein R, Saaddine JB.
     Arch Ophthalmol. 2012 Jan 9.


117. The potential cost-effectiveness of amblyopia screening programs
     Rein DB, Wittenborn JS, Zhang X, Song M, Saaddine JB.
     J Pediatr Ophthalmol Strabismus. 2012 May 1;49(3):146-155.


118. Exploring household economic impacts of childhood diarrheal illnesses in 3 African settings
     Rheingans R, Kukla M, Adegbola RA, Saha D, Omore R, Breiman RF, Sow SO, Onwuchekwa U, Nasrin D, Farag TH, Kotloff KL, Levine MM.
     Clin Infect Dis. 2012 Dec;55 Suppl 4:S317-26.


119. Long-term trends in Medicare payments in the last year of life
     Riley GF, Lubitz JD.
     Health Serv Res. 2010 Feb 9.


120. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship
     Roberts RR, Hota B, Ahmad I, Scott II RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA.
     Clin Infect Dis. 2009 Sep 9;49(8):1175-84.


121. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods
     Roberts RR, Scott 2nd RD, Hota B, Kampe LM, Abbasi F, Schabowski S, Ahmad I, Ciavarella GG, Cordell R, Solomon SL, Hagtvedt R, Weinstein RA.
     Med Care. 2010 Oct 11.


122. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States
     Saraiya M, McCaig LF, Ekwueme DU.
     Am J Manag Care. 2010 ;16(6):e137-44.


123. How health insurance design affects access to care and costs, by income, in eleven countries
     Schoen C, Osborn R, Squires D., Doty MM, Pierson R, Applebaum S.
     Health Affairs. 2010 Nov 2010;29(12).


124. The economic value of improving the health of disadvantaged Americans
     Schoeni RF, Dow WH, Miller WD, Pamuk ER.
     Am J Prev Med. 2011 Jan;40(1 Suppl 1):S67-72.


125. Role of health insurance in financing vaccinations for children and adolescents in the United States
     Shen AK, Hunsaker J, Gazmararian JA, Lindley MC, Birkhead GS.
     Pediatrics. 2009 ;124(SUPPL. 5):S522-S531.


126. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States
     Shen AK, Rodewald LE, Birkhead GS.
     Pediatrics. 2009 ;124(SUPPL. 5):S540-S547.


127. Costs and effectiveness of partner counseling and referral services with rapid testing for HIV in Colorado and Louisiana, United States
     Shrestha RK, Begley EB, Hutchinson AB, Sansom SL, Song B, Voorhees K, Busby A, Carrel J, Burgess S.
     Sex Transm Dis. 2009 ;36(10):637-641.


128. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions
     Shrestha RK, Sansom SL, Farnham PG.
     J Public Health Manag Pract. 2012 May;18(3):259-67.


129. Medical expenditures associated with diabetes among privately insured U.S. youth in 2007
     Shrestha SS, Zhang P, Albright A, Imperatore G.
     Diabetes Care. 2011 May;34(5):1097-101.


130. Medical expenditures associated with diabetes acute complications in privately-insured U.S. youth
     Shrestha SS, Zhang P, Barker L, Imperatore G.
     Diabetes care. 2010 Sep 15.


131. Underinsurance and adolescent immunization delivery in the United States
     Smith PJ, Lindley MC, Shefer A, Rodewald LE.
     Pediatrics. 2009 ;124(SUPPL. 5):S515-S521.


132. Underinsurance and pediatric immunization delivery in the United States
     Smith PJ, Molinari NA, Rodewald LE.
     Pediatrics. 2009 ;124(SUPPL. 5):S507-S514.


133. Uninsurance among nonelderly adults with and without frequent mental and physical distress in the United States
     Strine TW, Zack M, Dhingra S, Druss B, Simoes E.
     Psychiatr Serv. 2011 Oct;62(10):1131-7.


134. Developing and testing a cost-assessment tool for cancer screening programs
     Subramanian S, Ekwueme DU, Gardner JG, Trogdon J.
     Am J Prev Med. 2009 Sep;37(3):242-7.


135. Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women
     Subramanian S, Trogdon J, Ekwueme DU, Gardner JG, Whitmire JT, Rao C.
     Med Care. 2010 Nov 12.


136. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009
     Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH.
     J Antimicrob Chemother. 2013 Mar;68(3):715-8.


137. Trends and characteristics of US emergency department visits, 1997-2007
     Tang N, Stein J, Hsia RY, Maselli JH, Gonzales R.
     JAMA. 2010 Aug 11;304(6):664-70.


138. State-level cancer treatment costs: how much and who pays?
     Tangka FK, Trogdon JG, Ekwueme DU, Guy GP, Nwaise I, Orenstein D.
     Cancer. 2013 Apr 4.


139. Cancer treatment cost in the United States
     Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA.
     Cancer. 2010 .


140. Cancer treatment cost in the United States: has the burden shifted over time?
     Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA.
     Cancer. 2010 May 10.


141. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in Kenya
     Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, Mintz ED, Widdowson MA.
     J Infect Dis. 2009 Nov 1;200 Suppl 1:S76-84.


142. The economic implications of influenza vaccination for adults with asthma
     Trogdon JG, Nurmagambetov TA, Thompson HF.
     Am J Prev Med. 2010 Nov;39(5):403-10.


143. State-level projections of cancer-related medical care costs: 2010 to 2020
     Trogdon JG, Tangka FK, Ekwueme DU, Guy GP, Nwaise I, Orenstein D.
     Am J Manag Care. 2012 Sep;18(9):525-32.


144. Patients' willingness to discuss trade-offs to lower their out-of-pocket drug costs
     Tseng CW, Waitzfelder BE, Tierney EF, Gerzoff RB, Marrero DG, Piette JD, Karter AJ, Curb JD, Chung R, Mangione CM, Crosson JC, Dudley RA.
     Arch Intern Med. 2010 Sep 13;170(16):1502-4.


145. The cost-effectiveness of interventions designed to reduce sodium intake
     Wang G, Labarthe D.
     J Hypertens. 2011 Jul 22.


146. Costs of heart failure-related hospitalizations in patients aged 18 to 64 years
     Wang G, Zhang Z, Ayala C, Wall HK, Fang J.
     Am J Manag Care. 2010 Oct;16(10):769-76.


147. The economic effect of Planet Health on preventing bulimia nervosa
     Wang LY, Nichols LP, Austin SB.
     Arch Pediatr Adolesc Med. 2011 Aug;165(8):756-62.


148. Health insurance and mortality in US adults
     Wilper A, Woolhandler S, Lasser K, McCormick D, Bor D, Himmelstein D.
     Am J Public Health. 2009 ;99(12):2289-95.


149. Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy
     Wong JB, Coates PM, Russell RM, Dwyer JT, Schuttinga JA, Bowman BA, Peterson SA.
     Nutr Rev. 2011 Sep;69(9):533-549.


150. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China
     Yin Z, Beeler Asay GR, Zhang L, Li Y, Zuo S, Hutin YJ, Ning G, Sandhu HS, Cairns L, Luo H.
     Vaccine. 2012 Aug 10;30(37):5569-77.


151. Cost effectiveness analysis of elementary school-located vaccination against influenza-results from a randomized controlled trial
     Yoo BK, Humiston SG, Szilagyi PG, Schaffer SJ, Long C, Kolasa M.
     Vaccine. 2013 Apr 19;31(17):2156-64.


152. Cost of universal influenza vaccination of children in pediatric practices
     Yoo BK, Szilagyi PG, Schaffer SJ, Humiston SG, Rand CM, Albertin CS, Vincelli P, Blumkin AK, Shone LP, Coleman MS.
     Pediatrics. 2009 ;124(SUPPL. 5):S499-S506.


153. Full coverage for hypertension drugs in rural communities in China
     Yu B, Zhang X, Wang G.
     Am J Manag Care. 2013 ;19(1):e22-9.


154. Global healthcare expenditure on diabetes for 2010 and 2030
     Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G.
     Diabetes Res Clin Pract. 2010 Feb 18.


155. Prices of unhealthy foods, food stamp program participation, and body weight status among U.S. low-income women
     Zhang Q, Chen Z, Diawara N, Wang Y.
     J Fam Econ Issues. 2011 Jun;32(2):245-256.


156. A nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 years
     Zhuo X, Zhang P, Gregg EW, Barker L, Hoerger TJ, Pearson-Clarke T, Albright A.
     Health Aff (Millwood). 2012 Jan;31(1):50-60.


157. External costs of risky health behaviors associated with leading actual causes of death in the US: a review of the evidence and implications for future research
     Zohrabian A, Philipson TJ.
     Int J Environ Res Public Health. 2010 Jun;7(6):2460-2472.